Published in Blood Weekly, July 2nd, 2009
"The aim of the study was to investigate whether visual symptoms reported after repeated administration of ivabradine at high doses could affect driving performance. This randomized, double-blind, placebo-controlled study was conducted in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.